<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04232189</url>
  </required_header>
  <id_info>
    <org_study_id>8003</org_study_id>
    <nct_id>NCT04232189</nct_id>
  </id_info>
  <brief_title>Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion</brief_title>
  <official_title>Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Family Planning Associates Medical Group, LTD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Planned Parenthood of Greater New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Presidential Women's Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a case-series multicenter study enrolling 800 pregnant people. Serum will be&#xD;
      collected from people seeking abortion and assayed at a qualified laboratory.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Knowledge of gestational age (GA) is essential for guiding abortion care. In 2016, Gynuity&#xD;
      Health Projects (GHP) launched a portfolio of research that aims to explore the possibility&#xD;
      of developing a blood or urine test for this purpose.The goal of the present study is to&#xD;
      validate initial study findings (protocol 8000) in a larger population of people seeking&#xD;
      abortion.&#xD;
&#xD;
      Staff will obtain a serum specimen from each participant before any cervical manipulation is&#xD;
      performed and before any abortifacient drug is administered. The site will send the specimens&#xD;
      to a central facility for storage until assay. Serum assays for PAPP-A and possibly other&#xD;
      proteins will be performed at a selected laboratory by qualified experts.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID 19 related recruitment problems&#xD;
  </why_stopped>
  <start_date type="Actual">November 12, 2019</start_date>
  <completion_date type="Actual">April 14, 2020</completion_date>
  <primary_completion_date type="Actual">April 14, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Negative Predictive Value 70 days</measure>
    <time_frame>1 day</time_frame>
    <description>Negative Predictive Value of Prespecified Protein Concentration in Serum for Predicting a GA of ≤70 days is &gt;95%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative Predictive Value 105 days</measure>
    <time_frame>1 day</time_frame>
    <description>Negative Predictive Value of Prespecified Protein Concentration in Serum for Predicting a GA of ≤105 days is &gt;95%</description>
  </primary_outcome>
  <enrollment type="Actual">275</enrollment>
  <condition>Pregnancy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention, just specimen collection</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and urine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant people seeking abortion at multiple clinics that provide abortion through at least&#xD;
        18 weeks of gestation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant and seeking medical or surgical abortion&#xD;
&#xD;
          -  Has had or will have an ultrasound on the day of study enrollment or earlier during&#xD;
             the current pregnancy&#xD;
&#xD;
          -  Able to provide blood and urine specimens before any trans-cervical procedure or&#xD;
             mifepristone ingestion&#xD;
&#xD;
          -  Not previously enrolled in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not meet Inclusion Criteria&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth G Raymond, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Presidential Women's Center</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Planning Associates</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60661</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Planned Parenthood of New York City</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>placental protein</keyword>
  <keyword>gestational age</keyword>
  <keyword>abortion</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

